Greek study to measure daily life impact of iron overload drug
Knowledge-focused
Not yet recruiting
This study looks at how thalassemia patients in Greece feel about their daily lives while taking a drug called deferasirox for iron overload from blood transfusions. Researchers will use a questionnaire to measure quality of life. The goal is to understand the real-world experien…
Sponsor: Elpen Pharmaceutical Co. Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC